Immunomodulation
Saturday, October 31st, 2009Two recent reports purport to show that PXD modifies the activity of both normal lymphocytes and leukaemic cells, with the suggestion that it might have therapeutic potential in the treatment of certain blood-related disorders including leukaemia and certain autoimmune diseases. The first report is as follows. Phenoxodiol, an anticancer isoflavene, induces immunomodulatory effects in vitro [...]